Company Filing History:
Years Active: 2007
Title: Françoise Goubin Gramatica: Innovator in Cdc25 Phosphatase Inhibitors
Introduction
Françoise Goubin Gramatica is a notable inventor based in Agen, France. He has made significant contributions to the field of biochemistry, particularly in the development of novel cdc25 phosphatase inhibitors. His work has implications for cancer research and therapeutic applications.
Latest Patents
Françoise Goubin Gramatica holds a patent for cdc25 phosphatase inhibitors. This invention focuses on novel compounds that inhibit cdc25-C, which are characterized by a specific chemical formula. The compounds include various substituents that enhance their efficacy and potential applications in medical treatments.
Career Highlights
Throughout his career, Françoise has been dedicated to advancing scientific knowledge and innovation. His work at the Société de Conseils de Recherches et D'applications Scientifiques (S.C.R.A.S.) has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Françoise has worked alongside talented colleagues such as Grégoire Prevost and Marie-Christine Brezak Pannetier. Their collaborative efforts have furthered the understanding and development of cdc25 phosphatase inhibitors.
Conclusion
Françoise Goubin Gramatica's contributions to the field of biochemistry through his innovative patents highlight his role as a significant inventor. His work continues to influence research and development in therapeutic applications.